Advancing Diagnosis and Treatment of Tardive Dyskinesia: Insights from Clinical Practice

Inside the report

1. 01 How TD presentsthe involuntary movements clinicians look for, and how often it is caught late
2. 02 Diagnosis in practicescreening habits, rating scales, and who owns the diagnosis between psychiatry and neurology
3. 03 The antipsychotic linkhow prescribers weigh TD risk against the need to keep the underlying condition controlled
4. 04 Treatment optionswhere VMAT2 inhibitors and other approaches sit in real-world management
5. 05 Management strategiesdose review, switching, and the conversations clinicians have with patients
6. 06 Quality of lifewhat patients and treaters say matters most, and where care falls short

What this report tells you

Tardive dyskinesia is under-recognised and under-treated. This report draws on practising psychiatrists and neurologists to describe how TD is actually spotted, diagnosed and managed in clinic today, and where the gaps are.

It covers screening and diagnosis, how prescribers balance TD risk against the antipsychotic that caused it, the place of current treatment options, and the management strategies clinicians rely on to protect quality of life.

The full report is available on request. Leave your details below and our team will email it to you.